Microfluidics

Researchers develop a new technology for studying how brain tumours interact with the blood-brain barrier to inform future treatment strategies.

A new microfluidic liver-on-a-chip platform offers drug developers a stable, scalable and sensitive testing ground for much-needed treatments in fatty liver disease.

Microfluidic device allows for precise control of growth factor gradients, mimicking natural spinal cord development in vitro.

A platform for rapidly profiling mutations and gene expression offers valuable insights into cancer biology

Assay combines microfluidics and next-generation sequencing to reveal more mutations than existing targeted gene tests

A microfluidic organ-on-a-chip device combines skin culture and testing capabilities to offer a substitute to animal testing

A magnetic method for polishing metals enables mold templates with
microscale features

A
composite film of microscale ‘energy directors’ improves the bonding of
plastics in high-precision microfluidic chips as a critical step toward mass
production

Rapid and cheap on-the-spot diagnoses for diseases such as tuberculosis and cancer are a step closer thanks to a new modular valve for microfluidic chips

A sensitive DNA profiling technique could improve scientists’ approach to fighting cancer drug resistance

Human nasal epithelial cells, cultured on a microchip, react to air pollutants just like they would in the upper airway

The A*STAR Singapore Institute of Manufacturing Technology establishes three new industry collaborations to further innovation in microfluidics